Erste Group


Huge COVID-19 related risk provision pushed down profit

31/07/20 -"• Loan loss provisions increased from releases of €7m in Q2 19 to expenses of €614m for Q2 20 due to COVID-19 • Net profit decreased by 84% to €59m for Q2 20 • Erste now estimates risk cost in the ..."

Pages
53
Language
English
Published on
31/07/20
You may also be interested by these reports :
01/09/26
We have decided to revisit our complacent valuation to align our recommendation with our fundamental sentiment that the stock should continue to ...

27/08/26
EssilorLuxottica (EL) (BUY; France) share price peaked in late 2026 and has shed 40% ytd. No small feat for a stock that used to be worth more than ...

25/08/26
We have updated our projections on SocGen, upgrading our 2026 projections (+10%), but downgrading our 2027 estimates (-17%). For 2026, our upgrade ...

21/08/26
In our previous paper on Handelsbanken (SELL; Sweden), we pointed out that the bank was suffering from its “Swedishness”, with the bank’s dependence ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO